[Ip-health] Infojustice Roundup - August 24, 2015

Michael Palmedo mpalmedo at wcl.american.edu
Mon Aug 24 09:58:17 PDT 2015

Infojustice Roundup  




Preliminary Analysis of Biologics Exclusivity in the Leaked Trans Pacific Partnership Agreement Text


[Sanya Reid Smith] Biologics at monopoly prices are extremely expensive and are a growing share of medicines, including life-saving medicines. The latest leaked TPP IP chapter proposes a monopoly of up to 12 years for biologics, even when they are not patented. Therefore what is defined as a 'biologic' that gets this exclusivity period for up to 7 years longer than chemical medicines in the leaked TPP IP chapter is very important. Click here for more. <http://infojustice.org/archives/34899> 


See also: Jing Luo and Aaron S. Kesselheim. The Trans-Pacific Partnership Agreement and Implications for Access to Essential Medicines. Journal of the American Medical Association. Link. <http://jama.jamanetwork.com/article.aspx?articleid=2430590> 




USTR Requests Comments for 2016 National Trade Estimate Report on Foreign Trade Barriers


[Mike Palmedo] The Office of the U.S. Trade Representative has issued a request for comments for the 2016 National Trade Estimate (NTE) Report on Foreign Trade Barriers. This is an annual report in which USTR seeks to identify "significant barriers to U.S. exports of goods, services, and U.S. foreign direct investment." The notice suggests that "commenters should submit information related to one or more of the following categories of foreign trade barriers ... (4) Lack of intellectual property protection (e.g., inadequate patent, copyright, and trademark regimes);" Comments are open to the public, and should be submitted electronically by October 28, 2015. Click here for more. <http://infojustice.org/archives/34879> 


MSF Statement on RCEP Trade Negotiations in Kuala Lumpur


[Médecins Sans Frontières] As the trade ministers of the 16 countries negotiating the Regional Comprehensive Economic Partnership (RCEP) meet in Kuala Lumpur this week to finalise provisions in the deal, Doctors Without Borders/Médecins Sans Frontières (MSF) is calling for the removal of damaging intellectual property provisions in the deal that would risk locking in high drug prices and endangering the health of millions of people across the globe. Click here for the full press release. <https://www.msfaccess.org/about-us/media-room/press-releases/msf-statement-rcep-trade-negotiations-kuala-lumpur> 




A Comparative Analysis of the Three-Step Tests in International Treaties


[Andrew F. Christie and Robin W. Wright] Abstract: Much of the literature on the three-step test focuses on its implementation in relation to one particular intellectual property regime only, usually copyright. That approach tends to limit analysis of the test to a comparison of the different steps of the test with each other. Such an approach is valuable, but it does not provide the full picture. What is missing is a comparison of the same step within the different versions of the test.  Click here for more. <http://infojustice.org/archives/34907> 


More information about the Ip-health mailing list